HIV-infected children with moderate/severe immune-suppression: Changes in the immune system after highly active antiretroviral therapy

Clinical and Experimental Immunology

Volumn 137, Issue 3, 2004, Pages 570-577

  Resino, S ^a   Galan I ^a   Perez A ^a   Leon J A ^b   Seoane, E ^a   Gurbindo, D ^a   Munõz Fernández, Ma Ángeles ^a  

^a HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^b HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

Author keywords

Cytokine; HAART; HIV infected children; Immunoglobulin; T cell subsets; TREC

Indexed keywords

ABACAVIR; ANTIRETROVIRUS AGENT; CD38 ANTIGEN; CD4 ANTIGEN; CD45 ANTIGEN; CD8 ANTIGEN; DIDANOSINE; EFAVIRENZ; GAMMA INTERFERON; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G3; INDINAVIR; LAMIVUDINE; MITOGENIC AGENT; NELFINAVIR; NEVIRAPINE; PADGEM PROTEIN; POKEWEED MITOGEN; SAQUINAVIR; STAVUDINE; T LYMPHOCYTE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; ZIDOVUDINE;

ADOLESCENT; ARTICLE; CHILD; CHILDHOOD DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE SEVERITY; DRUG EFFECT; FEMALE; FOLLOW UP; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE STATUS; IMMUNE SYSTEM; IMMUNOREACTIVITY; IMMUNOSUPPRESSIVE TREATMENT; INFANT; LEUKOCYTE COUNT; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; THYMUS; TREATMENT OUTCOME; VIRUS LOAD;

ADOLESCENT; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL DIVISION; CHILD; CHILD, PRESCHOOL; CYTOKINES; FEMALE; FOLLOW-UP STUDIES; HIV INFECTIONS; HIV-1; HUMANS; IMMUNE SYSTEM; IMMUNOCOMPROMISED HOST; IMMUNOGLOBULINS; IMMUNOLOGIC MEMORY; LYMPHOCYTE COUNT; MALE; MITOGENS;

EID: 4344560435     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2004.02583.x     Document Type: Article

References (56)

1. Correa R, Muñoz-Fernández MA. Viral phenotype affects the thymical production of new T cells in HIV-1 infected children. AIDS 2001; 15:1959-63.
2. + cell numbers and clinical staging. J Clin Invest 1989; 84:1892-9.
3. + memory T cells are the predominant population of HIV-1-infected lymphocytes in neonates and children. AIDS 1996; 10:1477-84.
4. Melvin AJ, Rodrigo AG, Mohan KM et al. HIV-1 dynamics in children. J Acquir Immune Defic Syndr Hum Retrovirol 1999; 20:508-13.
5. Melvin AJ, Mohan KM, Arcuino LA, Edelstein RE, Frenkel LM. Clinical, virologic and immunologic responses of children with advanced human immunodeficiency virus type 1 disease treated with protease inhibitors. Clin Exp Immunol 1997; 110:15-21.
6. van Rossum AM, Niesters HG, Geelen SP et al. Clinical and virologic response to combination treatment with indinavir, zidovudine, and lamivudine in children with human immunodeficiency virus-1 infection: a multicenter study in the Netherlands. On behalf of the Dutch Study Group for Children with HIV-1 infections. J Pediatr 2000; 136:780-8.
7. + T cells response to HAART in HIV-infected children: a observational study. Clin Infect Dis 2003; 37:1216-25.
8. Resino S, Bellón JM, Gurbindo D, Ramos JT, Leon JA, Muñoz-Fernández MA. Dynamics of progression markers in a non-study population of HIV-1 vertically infected infants with different antiretroviral treatments. Acta Paediatr 2002; 91:776-82.
9. Correa R, Muñoz-Fernández MA. Effect of HAART on thymic reconstitution of CD4 T lymphocytes in vertically HIV-infected children. AIDS 2002; 16:1181-3.
10. Douek DC, McFarland RD, Keiser PH. et al. Changes in thymic function with age and during the treatment of HIV infection. Nature 1998; 396:690-5.
11. Resino S, Sanchez-Ramon S, Bellon JM, Correa R, Abad ML, Munoz-Fernandez MA. Immunological recovery after 3 years' antiretroviral therapy in HIV-1-infected children. AIDS 2002; 16:483-6.
12. Ometto L, De Forni D, Patiri F et al. Immune reconstitution in HIV-1-infected children on antiretroviral therapy: role of thymic output and viral fitness. AIDS 2002; 16:839-49.
13. Hainaut M, Ducarme M, Schandene L et al. Age-related immune reconstitution during highly active antiretroviral therapy in human immunodeficiency virus type 1-infected children. Pediatr Infect Dis J 2003; 22:62-9.
14. Roos MT, Prins M, Koot M et al. Low T cell responses to CD3 plus CD28 monoclonal antibodies are predictive of development of AIDS. AIDS 1998; 12:1745-51.
15. Mosmann TR. Cytokine patterns during the progression to AIDS. Science 1994; 265:193-4.
16. Rautonen J, Rautonen N, Martin NL, Philip R, Wara DW. Serum interleukin-6 concentrations are elevated and associated with elevated tumor necrosis factor-alpha and immunoglobulin G and A concentrations in children with HIV infection. AIDS 1991; 5:1319-25.
17. Peruzzi M, Azzari C, Galli L, Vierucci A, De Martino M. Highly active antiretroviral therapy restores in vitro mitogen and antigen-specific T lymphocyte responses in HIV-1 perinatally infected children despite virological failure. Clin Exp Immunol 2002; 128:365-71.
18. + T lymphocyte regeneration after anti-retroviral therapy in HIV-1-infected children and adult patients. Clin Exp Immunol 2000; 119:493-8.
19. Munoz-Fernandez MA, Obregon E, Navarro J et al. Relationship of virologic, immunologic, and clinical parameters in infants with vertically acquired human immunodeficiency virus type 1 infection. Pediatr Res 1996; 40:597-602.
20. Centers for Disease Control and Prevention (CDCP). Guidelines for use of antiretroviral agents in pediatric HIV infection. MMWR 1998; 47:1-43.
21. Centers for Disease Control and Prevention (CDCP). Revised classification system for human immunodeficiency virus infection in children less than 13 years of age. MMWR CDC Surveill Summ 1994; 43:1-10.
22. Nicholson J, Kidd P, Mandy F, Livnat D, Kagan J. Three-color supplement to the NIAID DAIDS guideline for flow cytometric immunophenotyping. Cytometry 1996; 26:227-30.
23. + T lymphocyte subsets with the most commonly used markers to monitor HIV-1 infection in children treated with highly active antiretroviral therapy. AIDS Res Hum Retroviruses 2001; 17:525-32.
24. Nicholson JK, Hubbard M, Jones BM. Use of CD45 fluorescence and side-scatter characteristics for gating lymphocytes when using the whole blood lysis procedure and flow cytometry. Cytometry 1996; 26:16-21.
25. Bohler T, Walcher J, Holzl-Wenig G et al. Early effects of antiretroviral combination therapy on activation, apoptosis and regeneration of T cells in HIV-1-infected children and adolescents. AIDS 1999; 13:779-89.
26. Carpenter CC, Fischl MA, Hammer SM et al. Antiretroviral therapy for HIV infection in 1997. Updated recommendations of the International AIDS Society-USA panel. JAMA 1997; 277:1962-9.
27. Pakker NG, Notermans DW, de Boer RJ et al. Biphasic kinetics of peripheral blood T cells after triple combination therapy in HIV-1 infection: a composite of redistribution and proliferation. Nat Med 1998; 4:208-14.
28. Kelleher AD, Sewell WA, Cooper DA. Effect of protease therapy on cytokine secretion by peripheral blood mononuclear cells (PBMC) from HIV-infected subjects. Clin Exp Immunol 1999; 115:147-52.
29. + T lymphocyte regeneration after intensive chemotherapy. N Engl J Med 1995; 332:143-9.
30. + T cell regenerative pathways result in prolonged T cell subset imbalance after intensive chemotherapy. Blood 1997; 89:3700-7.
31. Mackall CL, Bare CV, Granger LA, Sharrow SO, Titus JA, Gress RE. Thymic-independent T cell regeneration occurs via antigen-driven expansion of peripheral T cells resulting in a repertoire that is limited in diversity and prone to skewing. J Immunol 1996; 156:4609-16.
32. Mackall CL, Hakim FT, Gress RE. T cell regeneration: all repertoires are not created equal. Immunol Today 1997; 18:245-51.
33. + T cells and T cell activation markers in HIV-1 infected children on HAART. Clin Exp Immunol 2001; 125:266-73.
34. Stanley SK, McCune JM, Kaneshima H et al. Human immunodeficiency virus infection of the human thymus and disruption of the thymic microenvironment in the SCID-hu mouse. J Infect Dis 1993; 168:810-7.
35. Bonyhadi ML, Rabin L, Salimi S et al. HIV induces thymus depletion in vivo. Nature 1993; 363:728-32.
36. Haynes BF, Markert ML, Sempowski GD, Patel DD, Hale LP. The role of the thymus in immune reconstitution in aging, bone marrow transplantation, and HIV-1 infection. Annu Rev Immunol 2000; 18:529-60.
37. Tanchot C, Rocha B. The organization of mature T cell pools. Immunol Today 1998; 19:575-9.
38. Brinchmann JE. Differential responses of T cell subsets: possible role in the immunopathogenesis of AIDS. AIDS 2000; 14:1689-700.
39. Hazenberg MD, Otto SA, Cohen Stuart JW et al. Increased cell division but not thymic dysfunction rapidly affects the T cell receptor excision circle content of the naive T cell population in HIV-1 infection. Nat Med 2000; 6:1036-42.
40. Hazenberg MD, Borghans JA, De Boer RJ, Miedema F. Thymic output: a bad TREC record. Nat Immunol 2003; 4:97-9.
41. Al-Harthi L, Marchetti G, Steffens CM, Poulin J, Sekaly R, Landay A. Detection of T cell receptor circles (TRECs) as biomarkers for de novo T cell synthesis using a quantitative polymerase chain reaction-enzyme linked immunosorbent assay (PCR-ELISA). J Immunol Meth 2000; 237:187-97.
42. + T helper cell depletion occurs. J Clin Invest 1988; 82:1908-14.
43. Sondergaard SR, Aladdin H, Ullum H, Gerstoft J, Skinhoj P, Pedersen BK. Immune function and phenotype before and after highly active antiretroviral therapy. J Acquir Immune Defic Syndr 1999; 21:376-83.
44. Ngo-Giang-Huong N, Candotti D, Goubar A et al. HIV type 1-specific IgG2 antibodies: markers of helper T cell type 1 response and prognostic marker of long-term nonprogression. AIDS Res Hum Retroviruses 2001; 17:1435-46.
45. Rautonen J, Rautonen N, Martin NL, Wara DW. HIV type 1 Tat protein induces immunoglobulin and interleukin 6 synthesis by uninfected peripheral blood mononuclear cells. AIDS Res Hum Retroviruses 1994; 10:781-5.
46. Amadori A, Zamarchi R, Veronese ML et al. B cell activation during HIV-1 infection. II. Cell-to-cell interactions and cytokine requirement. J Immunol 1991; 146:57-62.
47. Macchia D, Almerigogna F, Parronchi P, Ravina A, Maggi E, Romagnani S. Membrane tumour necrosis factor-alpha is involved in the polyclonal B-cell activation induced by HIV-infected human T cells. Nature 1993; 363:464-6.
48. Planella T, Cortes M, Martinez-Bru C, Barrio J, Sambeat MA, Gonzalez-Sastre F. The predictive value of several markers in the progression to acquired immunodeficiency syndrome. Clin Chem Laboratory Med 1998; 36:169-73.
49. Ullum H, Lepri AC, Katzenstein TL et al. Prognostic value of single measurements of beta-2-microglobulin, immunoglobulin A in HIV disease after controlling for CD4 lymphocyte counts and plasma HIV RNA levels. Scand J Infect Dis 2000; 32:371-6.
50. Aucouturier P, Couderc LJ, Gouet D et al. Serum immunogiobulin G subclass dysbalances in the lymphadenopathy syndrome and acquired immune deficiency syndrome. Clin Exp Immunol 1986; 63:234-40.
51. Katzenstein TL, Ullum H, Roge BT et al. Virological and immunological profiles among patients with undetectable viral load followed prospectively for 24 months. HIV Med 2003; 4:53-61.
52. Vigano A, Principi N, Crupi L, Onorato J, Vincenzo ZG, Salvaggio A. Elevation of IgE in HIV-infected children and its correlation with the progression of disease. J Allergy Clin Immunol 1995; 95:627-32.
53. Goetz DW, Webb EL Jr, Whisman BA, Freeman TM. Aeroallergen-specific IgE changes in individuals with rapid human immunodeficiency virus disease progression. Ann Allergy Asthma Immunol 1997; 78:301-6.
54. de Martino M, Rossi ME, Azzari C, Chiarelli F, Galli L, Vierucci A. Interleukin-6 synthesis and IgE overproduction in children with perinatal human immunodeficiency virus-type 1 infection. Ann Allergy Asthma Immunol 1999; 82:212-6.
55. Resino S, Bellon JM, Sanchez-Ramon S, Gurbindo D, Munoz-Fernandez MA. Clinical relevance of cytokine production in HIV-1 infection in children on antiretroviral therapy. Scand J Immunol 2000; 52:634-40.
56. Barcellini W, Rizzardi GP, Borghi MO, Fain C, Lazzarin A, Meroni PL. TH1 and TH2 cytokine production by peripheral blood mononuclear cells from HIV-infected patients. AIDS 1994; 8:757-62.